These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12825164)

  • 1. Human immunoglobulin as a treatment for West Nile virus infection.
    Agrawal AG; Petersen LR
    J Infect Dis; 2003 Jul; 188(1):1-4. PubMed ID: 12825164
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.
    Ben-Nathan D; Lustig S; Tam G; Robinzon S; Segal S; Rager-Zisman B
    J Infect Dis; 2003 Jul; 188(1):5-12. PubMed ID: 12825165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
    Shimoni Z; Niven MJ; Pitlick S; Bulvik S
    Emerg Infect Dis; 2001; 7(4):759. PubMed ID: 11585547
    [No Abstract]   [Full Text] [Related]  

  • 4. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.
    Haley M; Retter AS; Fowler D; Gea-Banacloche J; O'Grady NP
    Clin Infect Dis; 2003 Sep; 37(6):e88-90. PubMed ID: 12955669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of effective therapies against West Nile virus infection.
    Diamond MS
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):931-44. PubMed ID: 16307506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. West Nile virus envelope protein: role in diagnosis and immunity.
    Wang T; Anderson JF; Magnarelli LA; Bushmich S; Wong S; Koski RA; Fikrig E
    Ann N Y Acad Sci; 2001 Dec; 951():325-7. PubMed ID: 11797789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of prophylactic and therapeutic human immunoglobulin on West Nile virus infection.
    Rager-Zisman B; Ben Nathan D
    Isr Med Assoc J; 2003 Oct; 5(10):691. PubMed ID: 14719460
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody neutralizes West Nile virus.
    Eisenstein M
    Lab Anim (NY); 2005 Jun; 34(6):10. PubMed ID: 15924118
    [No Abstract]   [Full Text] [Related]  

  • 9. West Nile virus neutralization by US plasma-derived immunoglobulin products.
    Planitzer CB; Modrof J; Kreil TR
    J Infect Dis; 2007 Aug; 196(3):435-40. PubMed ID: 17597458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin for infectious diseases: tailor-made or universal?
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    J Infect Dis; 2003 Nov; 188(10):1610; author reply 1610-1. PubMed ID: 14624389
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically.
    Morelli MC; Sambri V; Grazi GL; Gaibani P; Pierro A; Cescon M; Ercolani G; Cavrini F; Rossini G; Capobianchi MR; Di Caro A; Menzo S; Pagliaro PP; Ghinelli F; Lazzarotto T; Landini MP; Pinna AD
    Clin Infect Dis; 2010 Aug; 51(4):e34-7. PubMed ID: 20597692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of West Nile virus-specific antibodies in viremic blood donors.
    Prince HE; Tobler LH; Yeh C; Gefter N; Custer B; Busch MP
    Clin Vaccine Immunol; 2007 Sep; 14(9):1228-30. PubMed ID: 17652525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.
    Julander JG; Winger QA; Olsen AL; Day CW; Sidwell RW; Morrey JD
    Antiviral Res; 2005 Feb; 65(2):79-85. PubMed ID: 15708634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral brachial plexopathy associated with West Nile virus meningoencephalitis.
    Almhanna K; Palanichamy N; Sharma M; Hobbs R; Sil A
    Clin Infect Dis; 2003 Jun; 36(12):1629-30. PubMed ID: 12802774
    [No Abstract]   [Full Text] [Related]  

  • 15. [A review on assays for detecting antibodies of West Nile virus infection].
    Chen X; Zeng ZL; Xie P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):969-72. PubMed ID: 20193239
    [No Abstract]   [Full Text] [Related]  

  • 16. West Nile virus encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin.
    Saquib R; Randall H; Chandrakantan A; Spak CW; Barri YM
    Am J Kidney Dis; 2008 Nov; 52(5):e19-21. PubMed ID: 18676077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
    Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
    J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case 22-2005: intravenous immune globulin in chronic lymphocytic leukemia.
    Newcom SR
    N Engl J Med; 2005 Oct; 353(17):1862-3; author reply 1862-3. PubMed ID: 16251548
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for West Nile virus infection.
    Secko D
    CMAJ; 2005 Sep; 173(6):591. PubMed ID: 16157719
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult-onset opsoclonus-myoclonus syndrome due to West Nile Virus treated with intravenous immunoglobulin.
    Hébert J; Armstrong D; Daneman N; Jain JD; Perry J
    J Neurovirol; 2017 Feb; 23(1):158-159. PubMed ID: 27473195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.